NCT03870048View on ClinicalTrials.gov

tDCS to Lower Neuropathic Pain and Fatigue in People With Multiple Sclerosis

NACompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

April 15, 2019

Primary Completion Date

March 30, 2020

Study Completion Date

March 30, 2020

Conditions
Multiple Sclerosis
Interventions
DEVICE

transcranial direct current stimulation

A tDCS device (Soterix) will deliver a small direct current through two sponge surface electrodes (5cm × 5cm, soaked with 15 mM NaCL). The positive electrode will be placed over the motor cortex representation of the more affected leg, and a second electrode will be placed on the forehead above the contralateral orbit.

Trial Locations (1)

52242

University of Iowa, Iowa City

All Listed Sponsors
collaborator

jkamholz

UNKNOWN

collaborator

Workman, Craig D., PhD

INDIV

lead

University of Iowa

OTHER

NCT03870048 - tDCS to Lower Neuropathic Pain and Fatigue in People With Multiple Sclerosis | Biotech Hunter | Biotech Hunter